Q4 2022 Holdings
Filed 2023-02-14 | 35 holdings | $151.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $49.9M | 4,319,940 | 33.0% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $29.6M | 1,880,286 | 19.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $22.1M | 495,823 | 14.6% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $18.7M | 462,111 | 12.4% |
| Celcuity Inc(CELC) | COM | 15102K100 | $18.6M | 1,327,952 | 12.3% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $9.3M | 1,010,359 | 6.2% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $2.7M | 498,315 | 1.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $65.4K | 1,659,111 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $59.0K | 2,020,166 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $43.6K | 5,303,557 | 0.0% |
| Merus N V | COM | N5749R100 | $42.3K | 2,732,567 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $36.0K | 5,738,500 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $29.4K | 537,076 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $27.2K | 913,621 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $20.4K | 1,150,505 | 0.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $18.3K | 591,437 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $17.5K | 688,445 | 0.0% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $15.9K | 739,661 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $14.0K | 127,156 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $13.8K | 1,643,500 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $13.6K | 1,099,407 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $13.3K | 598,385 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $13.1K | 590,705 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $10.4K | 223,494 | 0.0% |
| Imara Inc | COM | 45249V107 | $10.2K | 2,494,794 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $9.7K | 1,325,000 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $9.7K | 758,244 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.3K | 173,481 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $6.6K | 1,935,609 | 0.0% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $4.3K | 993,294 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $3.1K | 750,000 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $2.5K | 1,800,000 | 0.0% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $2.5K | 1,210,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.1K | 312,553 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $142 | 92,687 | 0.0% |